Political uncertainty sparked a selloff in US health care stocks in March and April.
Our multi-dimensional analysis of return and risk suggests that reducing our position size in this sector may be warranted.
Nevertheless, fundamental drivers of performance remain strong in the sector, and we will likely retain some exposure to pharmaceuticals and health care providers.
In September 2018, we suggested in this commentary that the time was right to explore further opportunities in US health care stocks, particularly in the pharmaceuticals and providers and services segments. Since then, however, political uncertainty has spawned an indiscriminate sell-off in many health care names, beginning in March 2019 and hitting lows around April 17 – even as equity markets continued to grind higher. The key point of uncertainty is whether a change in party power following the 2020 US elections could lead to sweeping health-care reform.
In this month’s commentary, we’ll revisit US health care stocks through the framework of our investment process. Rather than pondering the probability of a given election outcome and considering whether large-scale health care reform is likely to take shape in 18 months’ time – and then attempting to estimate earnings impact based on those probabilities – we rely instead on our well-defined investment processes and discipline to respond to this political uncertainty.
Before investing, consider the funds' investment objectives, risks, charges and expenses. To obtain a prospectus or summary prospectus which contains this and other information, call 1-800-997-7327, download a prospectus or summary prospectus now, or talk to your financial advisor. Read it carefully before investing.
Distributor: State Street Global Advisors Funds Distributors, LLC, member FINRA, SIPC, an indirect wholly owned subsidiary of State Street Corporation. References to State Street may include State Street Corporation and its affiliates. Certain State Street affiliates provide services and receive fees from the SSGA Funds.
THIS SITE IS INTENDED FOR U.S. INVESTORS ONLY.
No Offer/Local Restrictions
Nothing contained in or on the Site should be construed as a solicitation of an offer to buy or offer, or recommendation, to acquire or dispose of any security, commodity, investment or to engage in any other transaction. SSGA Intermediary Business offers a number of products and services designed specifically for various categories of investors. Not all products will be available to all investors. The information provided on the Site is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation.
All persons and entities accessing the Site do so on their own initiative and are responsible for compliance with applicable local laws and regulations. The Site is not directed to any person in any jurisdiction where the publication or availability of the Site is prohibited, by reason of that person's nationality, residence or otherwise. Persons under these restrictions must not access the Site.
Information for Non-U.S. Investors:
The products and services described on this web site are intended to be made available only to persons in the United States, and the information on this web site is only for such persons. Nothing on this web site shall be considered a solicitation to buy or an offer to sell a security to any person in any jurisdiction where such offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction.